Zhongguancun Science-Tech Leasing Co., Ltd. Files Prospectus for IPO

Dec 01, 2016 11:50 CST Updated 11:50

Institution Profile:Established in late 2012, the Company is a state-controlled domestic financial leasing pilot enterprise approved by the Ministry of Commerce and the State Administration of Taxation. With a registered capital of RMB 500 million, which is projected to increase to RMB 1 billion by the end of 2016, it is the first technology leasing company in China. Leveraging Zhongguancun Development Group, a key market-oriented integrated operation platform in the demonstration zone, the Company is committed to “promoting the integration of technology and finance to realize the dreams of tech entrepreneurs.” It focuses on providing efficient financial services and equipment leasing solutions for technology enterprises, aiming to achieve win-win development for both the technology and financial industries. Over the four years since its establishment, the Company has supported nearly 100 clients in the big health industry, with a total leasing disbursement of nearly RMB 3 billion. The Company has received numerous honors, including “Best Financial Leasing Company of 2014” from the China Financial Institutions Gold List, “Most Innovative Leasing Company of 2015,” and “Leasing Company of the Year” at the China Financial Leasing Annual Conference. The Company plans to serve 100–150 clients in the big health industry between 2017 and 2019, with total financial support amounting to RMB 3.5–5 billion.

Collaborative Projects:Zhongguancun Leasing offers a total of nine products tailored to the healthcare industry: sale-and-leaseback, direct leasing, vendor leasing, risk leasing, M&A leasing, venture capital leasing, operating leasing, project leasing, and cluster leasing. These products can meet the multi-level, specialized needs of clients in the broader health industry, either through customized standalone solutions or combined structures. They primarily support various sectors, including pharmaceuticals, medical devices, healthcare services, and Internet-plus-healthcare.

Cooperation Process:The cooperation process involves the enterprise submitting an application and preparing relevant documentation, followed by Zhongguancun Leasing conducting project initiation, due diligence, and preparation of a project report. The report is then submitted to the Review Committee for approval. Upon approval, project contracting and fund disbursement procedures are carried out. The period from the commencement of due diligence to project funding generally does not exceed 20 working days.

Cooperation Requirements:

Companies are required to have products (for pharmaceutical R&D and manufacturing enterprises, this is generally expected after the completion of Phase III clinical trials), possess core technologies, maintain mature business models, and generate cash flow. The company’s overall asset-to-liability ratio shall not exceed 70%, it must have been established for at least two years, and enterprises that have secured Series A financing will be given priority consideration.

Institution Address:No. 11, Anxiang Beili, Chaoyang District, Beijing, 12th Floor, Tower B, Beijing Chuangye Building

Institution Website:http://www.zgclease.com/